Skip to main content
PRME logo

PRME · Prime Medicine, Inc. · Executive Compensation

Track PRME — free
$3.84 +0.02 (+0.52%) At close · Nov 19
Market Cap
$698.58M
Shares
181.92M
Volume · Nov 19 3.99M Avg daily vol (3M) 4.59M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Allan Reine $3,894,187
Keith Gottesdiener $2,207,770
Ann Lee $1,550,116
Jeremy Duffield $1,317,797
Fiscal 2024
Executive Total
Allan Reine $4,623,802
Keith Gottesdiener $2,245,617
Jeremy Duffield $1,877,577
Fiscal 2023
Executive Total
Keith Gottesdiener $5,403,071
Ann Lee $2,264,362
Jeremy Duffield $2,260,230
Allan Reine —
Fiscal 2022
Executive Total
Richard Brudnick $1,443,954
Ann Lee $947,279
Keith Gottesdiener $924,044
Jeremy Duffield $871,957
Fiscal 2021
Executive Total
Ann Lee $4,315,840
Keith Gottesdiener $2,939,433

Executive changes

Person Change Filed
Svetlana Makhni Appointed 2026-04-16
Jeffrey Marrazzo Appointed 2025-05-19
Allan Reine, M.D. Appointed 2025-05-19
Allan Reine, M.D. Appointed 2025-05-19
Keith Gottesdiener, M.D.
“Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.”
Resigned 2025-05-19
Keith Gottesdiener, M.D.
“Dr. Gottesdiener’s decision to resign from the Board was not the result of any disagreement with the Company on any matter relating to the operations, policies or practices of the Company.”
Resigned 2025-05-19
Allan Reine Appointed 2024-01-05
Jeff Marrazzo Appointed 2023-05-11

Leadership

Key facts CIK 1894562 CUSIP 74168J101 13F (30d) 194 filings 179 filers Visit website Investor relations